Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is one of the most common causes of cancer death worldwide. In patients with metastatic colorectal cancer, combination treatment with several anti-cancer drugs is employed and improves overall survival in some patients. Nevertheless, most patients with metastatic disease are not cured owing to the drug resistance. Cancer stem cells are known to regulate resistance to chemotherapy. In the previous study, we established a novel three-dimensional organoid culture model from tumor colorectal tissues of human patients using an air–liquid interface (ALI) method, which contained numerous cancer stem cells and showed resistance to 5-fluorouracil (5-FU) and Irinotecan. Here, we investigate which inhibitor for stem cell-related signal improves the sensitivity for anti-cancer drug treatment in tumor ALI organoids. Treatment with Hedgehog signal inhibitors (AY9944, GANT61) decreases the cell viability of organoids compared with Notch (YO-01027, DAPT) and Wnt (WAV939, Wnt-C59) signal inhibitors. Combination treatment of AY9944 or GANT61 with 5-FU, Irinotecan or Oxaliplatin decreases the cell viability of tumor organoids compared with each anti-cancer drug alone treatment. Treatment with AY9944 or GANT61 inhibits expression of stem cell markers c-Myc, CD44 and Nanog, likely through the decrease of their transcription factor, GLI-1 expression. Combination treatment of AY9944 or GANT61 with 5-FU or Irinotecan also prevents colony formation of colorectal cancer cell lines HCT116 and SW480. These findings suggest that Hedgehog signals mediate anti-cancer drug resistance in colorectal tumor patient-derived ALI organoids and that the inhibitors are useful as a combinational therapeutic strategy against colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, inhibiting Hh signaling in CRC cells has been shown to be effective in reducing cell viability and expression of CSC markers and may also enhance chemosensitivity at least in some cellular contexts [200,201,202].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., & Brenner, M. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400067101 · Cited by 1,280
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche
Ootani, A., Li, X., Sangiorgi, E., Ho, Q. T., Ueno, H., Toda, S., Sugihara, H., Fujimoto, K., Weissman, I. L., Capecchi, M. R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1951 · Cited by 906
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
Cancer Stem Cells in Radiation Resistance
Rich, J. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0895 · Cited by 496
Varnat, F., Duquet, A., Malerba, M., Zbinden, M., Mas, C., Gervaz, P., & Ruiz i Altaba, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900039 · Cited by 463
Cited by
El-Husseiny, H. M., Mady, E. A., Hamabe, L., Abugomaa, A., Shimada, K., Yoshida, T., Tanaka, T., Yokoi, A., Elbadawy, M., & Tanaka, R. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100186 · Cited by 533
Self-citationOrganoid technology and applications in cancer research
Xu, H., Lyu, X., Yi, M., Zhao, W., Song, Y., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0662-9 · Cited by 345
Kumar, V., Vashishta, M., Kong, L., Wu, X., Lu, J. J., Guha, C., & Dwarakanath, B. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650772 · Cited by 255
Elbadawy, M., Usui, T., Yamawaki, H., & Sasaki, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092340 · Cited by 234
Self-citationThe Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
Das, P. K., Islam, F., & Lam, A. K. (2020) · Cells · doi:10.3390/cells9061392 · Cited by 210
Xu, H., Jiao, Y., Qin, S., Zhao, W., Chu, Q., & Wu, K. (2018) · Experimental Hematology & Oncology · doi:10.1186/s40164-018-0122-9 · Cited by 186
Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights
Farooqi, A. A., de la Roche, M., Djamgoz, M. B. A., & Siddik, Z. H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.01.001 · Cited by 156
Elbadawy, M., Usui, T., Mori, T., Tsunedomi, R., Hazama, S., Nabeta, R., Uchide, T., Fukushima, R., Yoshida, T., Shibutani, M., et al. (2019) · Cancer Science · doi:10.1111/cas.14118 · Cited by 103
Self-citationSignaling pathways in the regulation of cancer stem cells and associated targeted therapy
Wang, M., & Wu, M. (2022) · MedComm · doi:10.1002/mco2.176 · Cited by 108
Zhang, J., Fan, J., Zeng, X., Nie, M., Luan, J., Wang, Y., Ju, D., & Yin, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.022 · Cited by 90
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Shang, T., Jia, Z., Li, J., Cao, H., Xu, H., Cong, L., Ma, D., Wang, X., & Liu, J. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01684-4 · Cited by 100
Applications of human organoids in the personalized treatment for digestive diseases
Wang, Q., Guo, F., Jin, Y., & Ma, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01194-6 · Cited by 78
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“Nevertheless, inhibiting Hh signaling in CRC cells has been shown to be effective in reducing cell viability and expression of CSC markers and may also enhance chemosensitivity at least in some cellular contexts [200–202].”
Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
Xie, P., Mo, J., Liu, J., Li, X., Tan, L., Zhang, W., Zhou, H., & Liu, Z. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00529-1 · Cited by 85
Sun, Q., Yang, H., Liu, M., Ren, S., Zhao, H., Ming, T., Tang, S., Tao, Q., Chen, L., Zeng, S., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154227 · Cited by 83
3D tumor cultures for drug resistance and screening development in clinical applications
Peng, Z., Lv, X., Sun, H., Zhao, L., & Huang, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02281-2 · Cited by 88
Abugomaa, A., Elbadawy, M., Yamawaki, H., Usui, T., & Sasaki, K. (2020) · Cells · doi:10.3390/cells9010235 · Cited by 78
Self-citationDrug screening model meets cancer organoid technology
Liu, C., Qin, T., Huang, Y., Li, Y., Chen, G., & Sun, C. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100840 · Cited by 71
Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence
Čižmáriková, M., Michalková, R., Mirossay, L., Mojžišová, G., Zigová, M., Bardelčíková, A., & Mojžíš, J. (2023) · Biomolecules · doi:10.3390/biom13111653 · Cited by 84
Tumor organoid biobank-new platform for medical research
Xie, X., Li, X., & Song, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-29065-2 · Cited by 81
Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism
Elbadawy, M., Sato, Y., Mori, T., Goto, Y., Hayashi, K., Yamanaka, M., Azakami, D., Uchide, T., Fukushima, R., Yoshida, T., et al. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1919004 · Cited by 61
Self-citationWang, H., Yang, W., Qin, Q., Yang, X., Yang, Y., Liu, H., Lu, W., Gu, S., Cao, X., Feng, D., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01622-9 · Cited by 68
Khan, A. Q., Hasan, A., Mir, S. S., Rashid, K., Shahab Uddin, M. S., & Steinhoff, M. S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.03.002 · Cited by 69
Pò, A., Citarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Gianno, F., Sabato, C., Moretti, M., Smaele, E. D., Vacca, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70871-9 · Cited by 62
Elbadawy, M., Hayashi, K., Ayame, H., Ishihara, Y., Abugomaa, A., Shibutani, M., Hayashi, S., Hazama, S., Takenouchi, H., Nakajima, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112043 · Cited by 57
Self-citationEstablishment of 2.5D organoid culture model using 3D bladder cancer organoid culture
Abugomaa, A., Elbadawy, M., Yamanaka, M., Goto, Y., Hayashi, K., Mori, T., Uchide, T., Azakami, D., Fukushima, R., Yoshida, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66229-w · Cited by 57
Self-citationDevelopment of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
Elbadawy, M., Abugomaa, A., Yamawaki, H., Usui, T., & Sasaki, K. (2020) · Cancers · doi:10.3390/cancers12040777 · Cited by 59
Self-citationZhang, H., Steed, A., Co, M., & Chen, X. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.32 · Cited by 50
Elfadadny, A., El‐Husseiny, H. M., Abugomaa, A., Ragab, R. F., Mady, E. A., Aboubakr, M., Samir, H., Mandour, A. S., El‐Mleeh, A., El‐Far, A. H., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15759-5 · Cited by 52
Self-citationNobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy
Turdo, A., Glaviano, A., Pepe, G., Calapà, F., Raimondo, S., Fiori, M. E., Carbone, D., Basilicata, M. G., Sarno, V. D., Ostacolo, C., et al. (2021) · Cancers · doi:10.3390/cancers13163927 · Cited by 48
Extracellular Matrix-Based Hydrogels to Tailoring Tumor Organoids
Lee, H. J., Mun, S., Pham, D. M., & Kim, P. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01801 · Cited by 47
Signaling pathways in colorectal cancer: implications for the target therapies
Song, Y., Chen, M., Wei, Y., Ma, X., & Shi, H. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00178-y · Cited by 46
Pádua, D., Figueira, P., Ribeiro, I. C. G., Almeida, R., & Mesquita, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00442 · Cited by 49
Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer
Elbadawy, M., Usui, T., Yamawaki, H., & Sasaki, K. (2018) · Cancers · doi:10.3390/cancers10060164 · Cited by 41
Self-citationPatient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy
Wu, W., Li, X., & Yu, S. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.050 · Cited by 43
Marín, J. J. G., Macías, R. I. R., Monte, M. J., Herráez, E., Peleteiro‐Vigil, A., de Blas, B. S., Sanchon-Sanchez, P., Temprano, Á. G., Espinosa-Escudero, R. A., Lozano, E., et al. (2020) · Cancers · doi:10.3390/cancers12092605 · Cited by 44
Patrad, E., Khalighfard, S., Amiriani, T., Khori, V., & Alizadeh, A. M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00715-3 · Cited by 45
Targeting cancer drug resistance utilizing organoid technology
Chai, C., Ji, P., Xu, H., Tang, H., Wang, Z., Zhang, H., & Zhou, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114098 · Cited by 38
Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?
Abugomaa, A., & Elbadawy, M. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1715794 · Cited by 39
Self-citationElbadawy, M., Fujisaka, K., Yamamoto, H., Tsunedomi, R., Nagano, H., Ayame, H., Ishihara, Y., Mori, T., Azakami, D., Uchide, T., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113105 · Cited by 32
Self-citationThe Impact of Cancer Stem Cells in Colorectal Cancer
Radu, P., Zurzu, M., Tigora, A., Paic, V., Bratucu, M., Garofil, D., Surlin, V., Munteanu, A. C., Coman, I. S., Popa, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084140 · Cited by 30
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Benboubker, V., Ramzy, G. M., Jacobs, S., & Nowak-Sliwinska, P. M. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03173-x · Cited by 32
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Zhang, W. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236094 · Cited by 30
Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies
Galperin, I., Dempwolff, L., Diederich, W. E., & Lauth, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00188 · Cited by 30
Garcinone C suppresses colon tumorigenesis through the Gli1-dependent hedgehog signaling pathway
Chen, J., Qiu, S., Kim, J. T., Cho, J. S., Moon, J. H., Zhou, Y., Auh, J., & Lee, H. J. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153334 · Cited by 27
Elbadawy, M., Tanabe, K., Yamamoto, H., Ishihara, Y., Mochizuki, M., Abugomaa, A., Yamawaki, H., Kaneda, M., Usui, T., & Sasaki, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1243258 · Cited by 27
Self-citationYu, Y., Zhu, Y.-J., Xiao, Z., Chen, Y., Chang, X., Liu, Y., Tang, Q., & Zhang, H. (2022) · Biomarker Research · doi:10.1186/s40364-022-00421-0 · Cited by 29
The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers
Liang, Y., Yang, L., & Xie, J. (2021) · Cells · doi:10.3390/cells10082030 · Cited by 26
Sato, Y., Elbadawy, M., Suzuki, K., Tsunedomi, R., Nagano, H., Ishihara, Y., Yamamoto, H., Azakami, D., Uchide, T., Nabeta, R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114651 · Cited by 23
Self-citationZhou, H., Han, L., Wang, H., Wei, J., Guo, Z., & Li, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7126976 · Cited by 23
RetractedEstablishment of a direct 2.5D organoid culture model using companion animal cancer tissues
Abugomaa, A., Elbadawy, M., Yamamoto, H., Ayame, H., Ishihara, Y., Sato, Y., Yamawaki, H., Kaneda, M., Usui, T., & Sasaki, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113597 · Cited by 25
Self-citationChang, S., Sun, G., Zhang, D., Li, Q., Wan, Y., Zhou, X., Lu, Q., Han, X., Chen, X., Xing, T., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02789-z · Cited by 21
Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents
Kim, M., Bakyt, L., Akhmetkaliyev, A., Toktarkhanova, D., & Bulanin, D. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032122 · Cited by 22
Bhattacharjya, D., & Sivalingam, N. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03189-2 · Cited by 25
Advanced Animal Replacement Testing Strategies Using Stem Cell and Organoids
Lee, C.-J., Nam, Y., Rim, Y. A., & Ju, J. H. (2025) · International Journal of Stem Cells · doi:10.15283/ijsc24118 · Cited by 23
Kobayashi, Y., Hashizume, H., Takiguchi, S., Ji, J., Kawano, R., Koiwai, K., Yamamoto, H., Elbadawy, M., Omatsu, T., Abugomaa, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-84297-0 · Cited by 23
Self-citationZhang, R., Ma, J., Avery, J. T., Sambandam, V., Nguyen, T. H.-A., Xu, B., Suto, M. J., & Boohaker, R. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00241 · Cited by 22
Unearthing the Janus-face cholesterogenesis pathways in cancer
Madan, B., Virshup, D. M., Nes, W. D., & Leaver, D. J. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114611 · Cited by 20
Sementino, E., Kadariya, Y., Cheung, M., Menges, C. W., Tan, Y., Kukuyan, A.-M., Shrestha, U., Karchugina, S., Cai, K. Q., Peri, S., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0837 · Cited by 18
Briede, I., Balodis, D., Gardovskis, J., & Štrumfa, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312891 · Cited by 19
B7-H4 induces epithelial–mesenchymal transition and promotes colorectal cancer stemness
Feng, Y., Yang, Z., Zhang, C., Che, N., Liu, X., & Xuan, Y. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153323 · Cited by 19
Chen, H., Yang, D., Wang, Y., Tao, H., Luo, Y., Wu, A., Li, S., Yang, Z., & Chen, M. (2022) · Journal of Cancer · doi:10.7150/jca.63410 · Cited by 18
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Lamichhane, A., & Tavana, H. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00798-y · Cited by 18
Si, Y., Li, L., Zhang, W., Liu, Q., & Liu, B. (2022) · Oncology Reports · doi:10.3892/or.2022.8397 · Cited by 13
“Previous studies have clarified that the Hh signalling pathway promotes progres‑ sion and mediates chemoresistance in CRC (14,34,35).”
Secretase promotes AD progression: simultaneously cleave Notch and APP
Yang, K.-F., Zhang, J., Feng, M., Yao, K., Liu, Y.-Y., Zhou, M.-S., & Jia, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1445470 · Cited by 15
Furbo, S., Urbano, P. C. M., Raskov, H., Troelsen, J. T., Fiehn, A. K., & Gögenür, I. (2022) · Cancers · doi:10.3390/cancers14041069 · Cited by 14
Establishment of a bat lung organoid culture model for studying bat-derived infectious diseases
Elbadawy, M., Saito, N., Kato, Y., Hayashi, K., Abugomaa, A., Kobayashi, M., Yoshida, T., Shibutani, M., Kaneda, M., Yamawaki, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-88621-0 · Cited by 13
Self-citationColorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Taglieri, M., Gregorio, L. D., Matis, S., Uras, C. R. M., Ardy, M., Casati, S., Marchese, M., Poggi, A. D., Raffaghello, L., & Benelli, R. (2025) · Cells · doi:10.3390/cells14060457 · Cited by 13
Gunter, N. V., Teh, S. S., Jantan, I., Céspedes, C. L., & Mah, S. H. (2022) · Phytochemistry Reviews · doi:10.1007/s11101-022-09846-9 · Cited by 12
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
Gao, Y., Julio, M. K., Peng, R., & Dorn, P. (2022) · Cancers · doi:10.3390/cancers14153758 · Cited by 14
Fiorentino, F., Fabbrizi, E., Raucci, A., Noce, B., Fioravanti, R., Valente, S., Paolini, C., Maria, R. D., Steinkühler, C., Gallinari, P., et al. (2024) · ChemMedChem · doi:10.1002/cmdc.202300655 · Cited by 11
van der Graaff, D., Seghers, S., Vanclooster, P., Deben, C., Vandamme, T., & Prenen, H. (2024) · Cancers · doi:10.3390/cancers16152671 · Cited by 11
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signaling
Mancini, C., Lori, G., Mattei, G., Iozzo, M., Desideri, D., Cianchi, F., Fortuna, L., Passagnoli, F., Massi, D., Ugolini, F., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03447-y · Cited by 12
Impact of SOX2 function and regulation on therapy resistance in bladder cancer
Chen, G., Chen, Y., Xu, R., Zhang, G., Zou, X., & Wu, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1020675 · Cited by 11
Tissue-specific cancer stem/progenitor cells: Therapeutic implications
Yehya, A., Youssef, J., Hachem, S., Ismael, J., & Abou-Kheir, W. G. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i5.323 · Cited by 13
Trocchianesi, S., Pò, A., Citarella, A., Spinello, Z., Rughetti, A., Besharat, Z. M., Autilio, T. M., Pecce, V., Verrienti, A., Elisei, R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114995 · Cited by 10
Li, S., Yang, K., Jin, Z., Yan, P., Wei, Y., Li, J., Xu, M., Guo, X., Xing, Q., Zhang, H., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112720 · Cited by 9
Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance
Panda, S. K., Robinson, N., & Desiderio, V. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189205 · Cited by 7
Zahra, M., Zahra, U. B., Abrahamse, H., & George, B. P. A. (2025) · RSC Advances · doi:10.1039/d5ra07380d · Cited by 8
Wang, T., Jiang, W., Yang, L., Li, J., Sun, Y., & Shi, J. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108948 · Cited by 6
Lü, J., Cao, L., Xu, Y., Huang, X., Cho, S., Ashktorab, H., Smoot, D. T., Li, P., Zheng, C., Kim, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.009 · Cited by 6
RetractedXu, R., Yang, X., Yao, K., Yang, K.-F., Hu, L., Zhan, X.-Y., Zhou, M.-S., & Jia, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189386 · Cited by 5
Using organoid models to predict chemotherapy efficacy: the future of precision oncology?
Forsythe, S. D., Pu, T., & Skardal, A. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1685868 · Cited by 6
Heilijgers, F., Bakker, M.-C., van Hest, B., Franken, I. A., Speetjens, F. M., Peeters, K. C. M. J., Roodhart, J. M. L., & Mesker, W. E. (2026) · Targeted Oncology · doi:10.1007/s11523-026-01220-5 · Cited by 6
Generation and characterization of feline colorectal adenocarcinoma organoids as a preclinical model
Kanaya, A., Nabeta, R., Ting-Wei, Y. U., Yamamoto, H., Yishan, L. I. U., Abugomaa, A., Elbadawy, M., Shimoda, K., Usui, T., & Uchide, T. (2025) · Journal of Veterinary Medical Science · doi:10.1292/jvms.24-0499 · Cited by 2
Self-citationChemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy
Mladenić, K., & Sedić, M. (2021) · Clinical Cancer Drugs · doi:10.2174/2212697x08666211206102503 · Cited by 2
Understanding and Targeting the Colon Cancer Pathogenesis: A Molecular Perspective
Khan, I. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e20354 · Cited by 2
Cancer Stem Cells in Therapy Resistance of Colorectal Cancer
Yang, Y., Meng, W., & Wang, Z. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_102-1 · Cited by 1
HASHIMOTO, I., Oue, N., Kimura, Y., Hiroshima, Y., Hara, K., Maezawa, Y., Kano, K., Fujikawa, H., Aoyama, T., Numata, M., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14599
Cancer Stem Cells in Therapy Resistance of Colorectal Cancer
Yang, Y., Meng, W., & Wang, Z. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_102
Wang, H., Yang, W., Qin, Q., Yang, X., Yang, Y., Liu, H., Lu, W., Gu, S., Cao, X., Feng, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20356432
Wang, H., Yang, W., Qin, Q., Yang, X., Yang, Y., Liu, H., Lu, W., Gu, S., Cao, X., Feng, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20356429
Wang, H., Yang, W., Qin, Q., Yang, X., Yang, Y., Liu, H., Lu, W., Gu, S., Cao, X., Feng, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20356435
Wang, H., Yang, W., Qin, Q., Yang, X., Yang, Y., Liu, H., Lu, W., Gu, S., Cao, X., Feng, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20356426
Edwards, G. O., Causi, F. S. L., Castagnola, G., Singh, S., & Amendola, P. G. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1777400
Shen, J., Ma, Y., Wang, Y., Yang, M., Liang, T., & Guo, L. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118184 · Cited by 1
BindingDB (2021) · UC San Diego · doi:10.7270/q2r214np
Metadata
- Authors
- Usui, T., Sakurai, M., Umata, K., Elbadawy, M., Ohama, T., Yamawaki, H., Hazama, S., Takenouchi, H., Nakajima, M., Tsunedomi, R., Suzuki, N., Nagano, H., Sato, K., Kaneda, M., & Sasaki, K.
- Affiliations
- Tokyo University of Agriculture and Technology (JP)
- Yamaguchi University (JP)
- Benha University (EG)
- Kitasato University (JP)
- Corresponding author
- Usui, Tatsuya
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-06
- Volume
- 19
- Issue
- 4
- Pages
- 1098
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979580
- OpenAlex
- W2796200410
- Cited by
- 96
- References
- 39
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 10 · 2023: 7 · 2022: 23 · 2021: 15 · 2020: 16 · 2019: 6 · 2018: 3
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (16K10574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- Hedgehog signaling, drug resistance, colorectal cancer, cancer stem cells, organoid culture, air-liquid interface, 5-fluorouracil, irinotecan, oxaliplatin, Hedgehog pathway inhibitors, AY-9944, GANT61, Gli1, c-Myc, CD44, Nanog, combination therapy, patient-derived tumor organoids
- MeSH terms
- Zinc Finger Protein GLI1, Irinotecan, Oxaliplatin, trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride, Camptothecin, Fluorouracil, Humans, Organoids, Organoplatinum Compounds, Pyridines, Pyrimidines, Neoplastic Stem Cells, Colorectal Neoplasms, Proto-Oncogene Proteins c-myc, Hyaluronan Receptors, Drug Resistance, Neoplasm, HCT116 Cells, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.